Mark W. Hahn is CFO at Verona Pharma plc (VRNA). They have made 4 open-market trades across 2 companies since 2018, most recently 2025-10-13.
CIK 0001408502
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $16K since 2018, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRNA | SELL · 10b5-1 | 2025-08-01 | 2025-08-05 | $13.14 | $5.5M | +0.0% | +0.9% | N/A |
| VRNA | SELL · 10b5-1 | 2025-06-11 | 2025-06-13 | $11.40 | $4.6M | +0.2% | +11.1% | +12.9% |
| VRNA | SELL · 10b5-1 | 2025-05-27 | 2025-05-29 | $9.33 | $7.5M | +9.5% | +19.3% | +33.5% |
| VRNA | SELL · 10b5-1 | 2025-05-01 | 2025-05-05 | $9.02 | $7.0M | -2.0% | +18.4% | +48.7% |
| VRNA | SELL · 10b5-1 | 2025-04-29 | 2025-05-01 | $8.98 | $1.6M | -7.1% | +15.6% | +44.5% |
| VRNA | SELL · 10b5-1 | 2024-12-04 | 2024-12-06 | $5.01 | $8.5M | -1.1% | +10.6% | +62.1% |
| VRNA | SELL · 10b5-1 | 2024-11-27 | 2024-12-02 | $5.01 | $1.1M | +1.2% | +24.2% | +70.0% |
| VRNA | SELL · 10b5-1 | 2024-11-25 | 2024-11-26 | $5.00 | $12K | +0.5% | +16.8% | +64.0% |
| VRNA | SELL · 10b5-1 | 2024-11-11 | 2024-11-13 | $5.00 | $12K | +5.8% | +10.5% | +58.3% |
| VRNA | SELL · 10b5-1 | 2024-11-01 | 2024-11-05 | $4.39 | $1.1M | -7.1% | +4.2% | +53.6% |
| VRNA | SELL · 10b5-1 | 2024-10-24 | 2024-10-25 | $4.38 | $1.3M | +10.6% | +16.7% | +59.1% |
| VRNA | SELL · 10b5-1 | 2024-10-18 | 2024-10-22 | $4.38 | $4.6M | +1.3% | +9.6% | +54.9% |
| VRNA | SELL · 10b5-1 | 2024-09-11 | 2024-09-13 | $3.76 | $2.3M | -5.2% | +14.9% | +31.7% |
| VRNA | SELL · 10b5-1 | 2024-08-12 | 2024-08-14 | $3.20 | $2.5M | -3.7% | +7.5% | +40.7% |
| VRNA | SELL · 10b5-1 | 2023-08-03 | 2023-08-07 | $2.52 | $992K | -7.2% | +1.1% | -20.7% |
| VRNA | SELL · 10b5-1 | 2023-08-01 | 2023-08-03 | $2.64 | $950K | -10.0% | -3.4% | -29.3% |
| VRNA | SELL · 10b5-1 | 2023-05-01 | 2023-05-03 | $2.58 | $2.4M | -0.5% | +2.1% | +2.0% |
| VRNA | SELL | 2023-02-01 | 2023-02-03 | $2.56 | $2.1M | +2.4% | +5.5% | -1.9% |
| VRNA | SELL | 2022-12-20 | 2022-12-21 | $2.12 | $1.3M | +11.9% | +1.2% | -12.7% |
| VRNA | SELL · 10b5-1 | 2022-11-01 | 2022-11-03 | $1.67 | $22K | -3.6% | +5.8% | +62.1% |
| VRNA | SELL | 2022-08-09 | 2022-08-11 | $1.75 | $1.1M | -11.2% | -14.5% | +4.7% |
| VRNA | SELL · 10b5-1 | 2022-08-01 | 2022-08-03 | $0.70 | $9K | +113.0% | +75.8% | +125.1% |
| VRNA | SELL · 10b5-1 | 2022-05-03 | 2022-05-05 | $0.50 | $6K | +1.7% | +25.9% | +46.5% |
| VRNA | SELL · 10b5-1 | 2022-02-02 | 2022-02-03 | $0.76 | $8K | +4.2% | -13.7% | -29.6% |
| VRNA | SELL · 10b5-1 | 2021-11-02 | 2021-11-03 | $0.65 | $7K | +4.3% | -11.8% | +21.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.